(Total Views: 233)
Posted On: 05/20/2019 11:44:50 AM
Post# of 155054
We are on the same page misiu, our crazy share price and valuation is thing needed to get this more in-line with any typical models (PS, PE, etc.).
The reference to Gilead that you mention and NP has mentioned many times, is their inflection point occurred because they were not bought out. I hope this is the intent of management and the BOD as this will be a play we can stay in longer term and reap more of the benefits of leronlimab's success......and hopefully based on PS or PE valuations!
The reference to Gilead that you mention and NP has mentioned many times, is their inflection point occurred because they were not bought out. I hope this is the intent of management and the BOD as this will be a play we can stay in longer term and reap more of the benefits of leronlimab's success......and hopefully based on PS or PE valuations!
(0)
(0)
Please do your own due diligence. All my posts and comments are not to be considered investment advice.
